About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
A workplace of inclusion, equal opportunity and respect lives at the heart of Novartis culture and is an integral part of everything we do. It is key to driving innovation and business performance as ...
Novartis is reimagining medicine to improve and extend people’s lives. We provide financial support for educational, advocacy and outreach activities that help advance our goals of improving patient ...
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Leader mondial dans le domaine de la santé, Novartis propose actuellement l’un des portefeuilles les plus complets du marché. Un portefeuille de médicaments innovants, développés par des personnes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback